Jason spent over 30 years in Biotechnology in various senior operations roles as well as responsibility as head of business in global organizations. Jason played a critical role in innovation and expansion of cell and gene therapy over the last 20 years. Utilizing our fully autonomous Robotics technology, we are able to control and maintain sterile closed processes in cell therapy, while minimizing manual touchpoints, and de-bottlenecking manufacturing, we can ultimately achieve higher levels of patient access to life saving therapies.

Previously, Jason held leadership roles in business and operations, M&A, Strategic Alliances, and capital project management at Becton Dickinson, Rentschler Bio, Miltenyi Biotec,  Lonza Biologics and AGC Bio.